David Colleran - Net Worth and Insider Trading
David Colleran Net Worth
The estimated net worth of David Colleran is at least $8 Million dollars as of 2024-11-29. David Colleran is the SVP, Secretary and GC of Insulet Corp and owns about 30,433 shares of Insulet Corp (PODD) stock worth over $8 Million. David Colleran is also the EVP, General Counsel, Corp Sec of Anika Therapeutics Inc and owns about 9,867 shares of Anika Therapeutics Inc (ANIK) stock worth over $174,843. Details can be seen in David Colleran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Colleran has not made any transactions after 2022-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Colleran
David Colleran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Colleran owns 2 companies in total, including Anika Therapeutics Inc (ANIK) , and Insulet Corp (PODD) .
Click here to see the complete history of David Colleran’s form 4 insider trades.
Insider Ownership Summary of David Colleran
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ANIK | Anika Therapeutics Inc | 2022-05-11 | EVP & General Counsel & Corp Sec |
PODD | Insulet Corp | 2019-04-02 | Secretary and General Counsel |
David Colleran Latest Holdings Summary
David Colleran currently owns a total of 2 stocks. Among these stocks, David Colleran owns 30,433 shares of Insulet Corp (PODD) as of April 2, 2019, with a value of $8 Million and a weighting of 97.89%. David Colleran also owns 9,867 shares of Anika Therapeutics Inc (ANIK) as of May 11, 2022, with a value of $174,843 and a weighting of 2.11%.
Latest Holdings of David Colleran
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PODD | Insulet Corp | 2019-04-02 | 30,433 | 266.92 | 8,123,176 |
ANIK | Anika Therapeutics Inc | 2022-05-11 | 9,867 | 17.72 | 174,843 |
Holding Weightings of David Colleran
David Colleran Form 4 Trading Tracker
According to the SEC Form 4 filings, David Colleran has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 7,395 shares on April 2, 2019, which brought David Colleran around $701,712.
According to the SEC Form 4 filings, David Colleran has made a total of 2 transactions in Anika Therapeutics Inc (ANIK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Anika Therapeutics Inc is the acquisition of 1,500 shares on May 11, 2022, which cost David Colleran around $32,055.
Insider Trading History of David Colleran
- 1
David Colleran Trading Performance
GuruFocus tracks the stock performance after each of David Colleran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Colleran is -8.49%. GuruFocus also compares David Colleran's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Colleran within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Colleran's insider trading performs compared to the benchmark.
Performance of David Colleran
David Colleran Ownership Network
David Colleran Owned Company Details
What does Anika Therapeutics Inc do?
Who are the key executives at Anika Therapeutics Inc?
David Colleran is the EVP & General Counsel & Corp Sec of Anika Therapeutics Inc. Other key executives at Anika Therapeutics Inc include SVP & Chief Operations Officer Anne Nunes , EVP & CFO & Treasurer Michael L Levitz , and EVP Business Development James Loerop .
Anika Therapeutics Inc (ANIK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Anika Therapeutics Inc (ANIK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anika Therapeutics Inc (ANIK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Anika Therapeutics Inc (ANIK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Anika Therapeutics Inc Insider Transactions
David Colleran Mailing Address
Above is the net worth, insider trading, and ownership report for David Colleran. You might contact David Colleran via mailing address: 600 Technology Park Drive, Suite 200, Billerica Ma 01821.